These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modulation of the nitric oxide synthase pathway in atherosclerosis. Maxwell AJ; Tsao PS; Cooke JP Exp Physiol; 1998 Sep; 83(5):573-84. PubMed ID: 9793778 [No Abstract] [Full Text] [Related]
6. Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants. Vásquez-Vivar J; Duquaine D; Whitsett J; Kalyanaraman B; Rajagopalan S Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1655-61. PubMed ID: 12377745 [TBL] [Abstract][Full Text] [Related]
7. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Kawashima S; Yokoyama M Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):998-1005. PubMed ID: 15001455 [TBL] [Abstract][Full Text] [Related]
8. NO or H(2)O(2) for endothelium-dependent vasorelaxation: Tetrahydrobiopterin makes the difference. van Hinsbergh VW Arterioscler Thromb Vasc Biol; 2001 May; 21(5):719-21. PubMed ID: 11348862 [No Abstract] [Full Text] [Related]
9. The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis. Kawashima S Endothelium; 2004; 11(2):99-107. PubMed ID: 15370069 [TBL] [Abstract][Full Text] [Related]
11. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Chalupsky K; Cai H Proc Natl Acad Sci U S A; 2005 Jun; 102(25):9056-61. PubMed ID: 15941833 [TBL] [Abstract][Full Text] [Related]
12. Lipid metabolism: interactions of lipids and nitric oxide in the atherogenic process. Davidson J; Rotondo D Curr Opin Lipidol; 2005 Apr; 16(2):249-51. PubMed ID: 15767864 [No Abstract] [Full Text] [Related]
13. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779 [TBL] [Abstract][Full Text] [Related]
16. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Channon KM Trends Cardiovasc Med; 2004 Nov; 14(8):323-7. PubMed ID: 15596110 [TBL] [Abstract][Full Text] [Related]
17. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice. Alp NJ; McAteer MA; Khoo J; Choudhury RP; Channon KM Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):445-50. PubMed ID: 14707037 [TBL] [Abstract][Full Text] [Related]
18. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cai S; Khoo J; Channon KM Cardiovasc Res; 2005 Mar; 65(4):823-31. PubMed ID: 15721862 [TBL] [Abstract][Full Text] [Related]
19. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Laursen JB; Somers M; Kurz S; McCann L; Warnholtz A; Freeman BA; Tarpey M; Fukai T; Harrison DG Circulation; 2001 Mar; 103(9):1282-8. PubMed ID: 11238274 [TBL] [Abstract][Full Text] [Related]
20. Antioxidants and the bioactivity of endothelium-derived nitric oxide. Tomasian D; Keaney JF; Vita JA Cardiovasc Res; 2000 Aug; 47(3):426-35. PubMed ID: 10963716 [No Abstract] [Full Text] [Related] [Next] [New Search]